These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 29073307)

  • 1. A follow-up history of young man with apparent cortisone reductase deficiency (ACRD) - several years after diagnosis.
    Zajkowska A; Rydzewska M; Wojtkielewicz K; Pomaski J; Romer T; Bossowski A
    Pediatr Endocrinol Diabetes Metab; 2017; 23(1):42-48. PubMed ID: 29073307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel H6PDH mutations in two girls with premature adrenarche: 'apparent' and 'true' CRD can be differentiated by urinary steroid profiling.
    Lavery GG; Idkowiak J; Sherlock M; Bujalska I; Ride JP; Saqib K; Hartmann MF; Hughes B; Wudy SA; De Schepper J; Arlt W; Krone N; Shackleton CH; Walker EA; Stewart PM
    Eur J Endocrinol; 2013 Feb; 168(2):K19-26. PubMed ID: 23132696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 11beta-hydroxysteroid dehydrogenase type 1 deficiency ('apparent cortisone reductase deficiency') in a 6-year-old boy.
    Małunowicz EM; Romer TE; Urban M; Bossowski A
    Horm Res; 2003; 59(4):205-10. PubMed ID: 12649576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cortisone-reductase deficiency associated with heterozygous mutations in 11beta-hydroxysteroid dehydrogenase type 1.
    Lawson AJ; Walker EA; Lavery GG; Bujalska IJ; Hughes B; Arlt W; Stewart PM; Ride JP
    Proc Natl Acad Sci U S A; 2011 Mar; 108(10):4111-6. PubMed ID: 21325058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genotypes at 11beta-hydroxysteroid dehydrogenase type 11B1 and hexose-6-phosphate dehydrogenase loci are not risk factors for apparent cortisone reductase deficiency in a large population-based sample.
    White PC
    J Clin Endocrinol Metab; 2005 Oct; 90(10):5880-3. PubMed ID: 16091483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Steroid biomarkers and genetic studies reveal inactivating mutations in hexose-6-phosphate dehydrogenase in patients with cortisone reductase deficiency.
    Lavery GG; Walker EA; Tiganescu A; Ride JP; Shackleton CH; Tomlinson JW; Connell JM; Ray DW; Biason-Lauber A; Malunowicz EM; Arlt W; Stewart PM
    J Clin Endocrinol Metab; 2008 Oct; 93(10):3827-32. PubMed ID: 18628520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations in the genes encoding 11beta-hydroxysteroid dehydrogenase type 1 and hexose-6-phosphate dehydrogenase interact to cause cortisone reductase deficiency.
    Draper N; Walker EA; Bujalska IJ; Tomlinson JW; Chalder SM; Arlt W; Lavery GG; Bedendo O; Ray DW; Laing I; Malunowicz E; White PC; Hewison M; Mason PJ; Connell JM; Shackleton CH; Stewart PM
    Nat Genet; 2003 Aug; 34(4):434-9. PubMed ID: 12858176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetics of adrenocortical disease: an update.
    Bar-Lev A; Annes JP
    Curr Opin Endocrinol Diabetes Obes; 2012 Jun; 19(3):159-67. PubMed ID: 22476103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Absence of Cushingoid phenotype in a patient with Cushing's disease due to defective cortisone to cortisol conversion.
    Tomlinson JW; Draper N; Mackie J; Johnson AP; Holder G; Wood P; Stewart PM
    J Clin Endocrinol Metab; 2002 Jan; 87(1):57-62. PubMed ID: 11788623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hexose 6-phosphate dehydrogenase (H6PD) and corticosteroid metabolism.
    White PC; Rogoff D; McMillan DR; Lavery GG
    Mol Cell Endocrinol; 2007 Feb; 265-266():89-92. PubMed ID: 17240046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel insight into etiology, diagnosis and management of primary adrenal insufficiency.
    Malikova J; Flück CE
    Horm Res Paediatr; 2014; 82(3):145-57. PubMed ID: 25096886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hexose-6-phosphate dehydrogenase confers oxo-reductase activity upon 11 beta-hydroxysteroid dehydrogenase type 1.
    Bujalska IJ; Draper N; Michailidou Z; Tomlinson JW; White PC; Chapman KE; Walker EA; Stewart PM
    J Mol Endocrinol; 2005 Jun; 34(3):675-84. PubMed ID: 15956339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of a disordered steroid metabolome in the elucidation of sterol and steroid biosynthesis.
    Shackleton CH
    Lipids; 2012 Jan; 47(1):1-12. PubMed ID: 21874273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered cortisol metabolism in polycystic ovary syndrome: insulin enhances 5alpha-reduction but not the elevated adrenal steroid production rates.
    Tsilchorozidou T; Honour JW; Conway GS
    J Clin Endocrinol Metab; 2003 Dec; 88(12):5907-13. PubMed ID: 14671189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Syndrome of apparent mineralocorticoid excess caused by a deficiency of 11 beta-hydroxysteroid dehydrogenase: clinical and genetic study in a Chilean family followed for 19 years].
    Rodríguez JA
    Rev Med Chil; 2000 Jan; 128(1):17-26. PubMed ID: 10883518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apparent cortisone reductase deficiency: a functional defect in 11beta-hydroxysteroid dehydrogenase type 1.
    Jamieson A; Wallace AM; Andrew R; Nunez BS; Walker BR; Fraser R; White PC; Connell JM
    J Clin Endocrinol Metab; 1999 Oct; 84(10):3570-4. PubMed ID: 10522997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hexose-6-phosphate dehydrogenase modulates 11beta-hydroxysteroid dehydrogenase type 1-dependent metabolism of 7-keto- and 7beta-hydroxy-neurosteroids.
    Nashev LG; Chandsawangbhuwana C; Balazs Z; Atanasov AG; Dick B; Frey FJ; Baker ME; Odermatt A
    PLoS One; 2007 Jun; 2(6):e561. PubMed ID: 17593962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Syndrome of apparent mineralocorticoid excess. A defect in the cortisol-cortisone shuttle.
    Stewart PM; Corrie JE; Shackleton CH; Edwards CR
    J Clin Invest; 1988 Jul; 82(1):340-9. PubMed ID: 3164727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The syndrome of apparent mineralocorticoid excess: its association with 11 beta-dehydrogenase and 5 beta-reductase deficiency and some consequences for corticosteroid metabolism.
    Monder C; Shackleton CH; Bradlow HL; New MI; Stoner E; Iohan F; Lakshmi V
    J Clin Endocrinol Metab; 1986 Sep; 63(3):550-7. PubMed ID: 3460996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cortisol metabolism in healthy young adults: sexual dimorphism in activities of A-ring reductases, but not 11beta-hydroxysteroid dehydrogenases.
    Finken MJ; Andrews RC; Andrew R; Walker BR
    J Clin Endocrinol Metab; 1999 Sep; 84(9):3316-21. PubMed ID: 10487705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.